Geron Corporation (NASDAQ: GERN) Stock Spikes as FDA Greenlights Rare Blood Cancer Therapy
Geron Corporation (NASDAQ: GERN) stock surged during intraday trading Friday after the biopharma company received FDA approval for RYTELO, a […]
NASDAQ: GERN
Geron Corporation (NASDAQ: GERN) Stock Skyrockets 85% – What’s The Buzz?
Geron Corporation (NASDAQ: GERN) stock soared 85% on Friday in response to reports indicating favorable backing from advisors to the
Geron Corporation (NASDAQ: GERN) Stock Skyrockets 85% – What’s The Buzz? Read More »
Geron Corporation (NASDAQ: GERN) Stock Plummets as FDA Raises Red Flags on Anemia Drug
Geron Corporation (NASDAQ: GERN) stock plunged over 12% on Tuesday following reports that FDA staff reviewers expressed several safety concerns
Geron Corporation (NASDAQ: GERN) Stock Plummets as FDA Raises Red Flags on Anemia Drug Read More »